Jingtong Xu

机构：Jilin University, First Affiliated Hospital of Guangzhou Medical University, First Hospital of Jilin University, Guangzhou Medical University · ORCID：0009-0007-5041-5860

发表论文 23 篇 · 总被引 271 次 · h-index 8

代表论文

• Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy (2023 · Frontiers in Immunology · 被引 68)
• APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance (2022 · EBioMedicine · 被引 41)
• Cell-cell communication characteristics in breast cancer metastasis (2024 · Cell Communication and Signaling · 被引 31)
• Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer (2024 · Acta Pharmaceutica Sinica B · 被引 28)
• Untangling the web of intratumor microbiota in lung cancer (2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 22)
• TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1 / PD‐L1 blockade response in urothelial carcinoma (2024 · The Journal of Pathology · 被引 13)